rs1551118

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001378609.3(OTOGL):​c.6421G>A​(p.Ala2141Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.808 in 1,525,446 control chromosomes in the GnomAD database, including 503,471 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.71 ( 40662 hom., cov: 32)
Exomes 𝑓: 0.82 ( 462809 hom. )

Consequence

OTOGL
NM_001378609.3 missense

Scores

15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 2.09
Variant links:
Genes affected
OTOGL (HGNC:26901): (otogelin like) The protein encoded by this gene belongs to the otogelin family. This gene is expressed in the inner ear of vertebrates with the highest level of expression seen at the embryonic stage and lowest in adult. Knockdown studies in zebrafish suggest that this gene is essential for normal inner ear function. Mutations in this gene are associated with autosomal recessive deafness. [provided by RefSeq, Dec 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=9.20896E-7).
BP6
Variant 12-80367650-G-A is Benign according to our data. Variant chr12-80367650-G-A is described in ClinVar as [Benign]. Clinvar id is 226969.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr12-80367650-G-A is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.833 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
OTOGLNM_001378609.3 linkc.6421G>A p.Ala2141Thr missense_variant Exon 54 of 59 ENST00000547103.7 NP_001365538.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
OTOGLENST00000547103.7 linkc.6421G>A p.Ala2141Thr missense_variant Exon 54 of 59 5 NM_001378609.3 ENSP00000447211.2 Q3ZCN5

Frequencies

GnomAD3 genomes
AF:
0.714
AC:
108418
AN:
151916
Hom.:
40660
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.457
Gnomad AMI
AF:
0.774
Gnomad AMR
AF:
0.702
Gnomad ASJ
AF:
0.840
Gnomad EAS
AF:
0.781
Gnomad SAS
AF:
0.813
Gnomad FIN
AF:
0.792
Gnomad MID
AF:
0.782
Gnomad NFE
AF:
0.839
Gnomad OTH
AF:
0.755
GnomAD2 exomes
AF:
0.765
AC:
137747
AN:
180070
AF XY:
0.778
show subpopulations
Gnomad AFR exome
AF:
0.444
Gnomad AMR exome
AF:
0.613
Gnomad ASJ exome
AF:
0.832
Gnomad EAS exome
AF:
0.760
Gnomad FIN exome
AF:
0.791
Gnomad NFE exome
AF:
0.833
Gnomad OTH exome
AF:
0.777
GnomAD4 exome
AF:
0.818
AC:
1123451
AN:
1373414
Hom.:
462809
Cov.:
33
AF XY:
0.820
AC XY:
558950
AN XY:
682006
show subpopulations
Gnomad4 AFR exome
AF:
0.436
AC:
12980
AN:
29790
Gnomad4 AMR exome
AF:
0.633
AC:
21185
AN:
33490
Gnomad4 ASJ exome
AF:
0.833
AC:
19838
AN:
23812
Gnomad4 EAS exome
AF:
0.770
AC:
28849
AN:
37446
Gnomad4 SAS exome
AF:
0.819
AC:
62811
AN:
76702
Gnomad4 FIN exome
AF:
0.799
AC:
40958
AN:
51292
Gnomad4 NFE exome
AF:
0.838
AC:
887064
AN:
1058406
Gnomad4 Remaining exome
AF:
0.800
AC:
45589
AN:
56968
Heterozygous variant carriers
0
9024
18048
27072
36096
45120
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
20018
40036
60054
80072
100090
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.713
AC:
108447
AN:
152032
Hom.:
40662
Cov.:
32
AF XY:
0.714
AC XY:
53070
AN XY:
74302
show subpopulations
Gnomad4 AFR
AF:
0.457
AC:
0.456844
AN:
0.456844
Gnomad4 AMR
AF:
0.702
AC:
0.702467
AN:
0.702467
Gnomad4 ASJ
AF:
0.840
AC:
0.840058
AN:
0.840058
Gnomad4 EAS
AF:
0.780
AC:
0.780426
AN:
0.780426
Gnomad4 SAS
AF:
0.812
AC:
0.812215
AN:
0.812215
Gnomad4 FIN
AF:
0.792
AC:
0.792164
AN:
0.792164
Gnomad4 NFE
AF:
0.839
AC:
0.838883
AN:
0.838883
Gnomad4 OTH
AF:
0.755
AC:
0.755208
AN:
0.755208
Heterozygous variant carriers
0
1381
2762
4142
5523
6904
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
820
1640
2460
3280
4100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.798
Hom.:
157450
Bravo
AF:
0.691
TwinsUK
AF:
0.833
AC:
3088
ALSPAC
AF:
0.844
AC:
3251
ESP6500AA
AF:
0.483
AC:
2123
ESP6500EA
AF:
0.839
AC:
7198
ExAC
AF:
0.753
AC:
90385
Asia WGS
AF:
0.781
AC:
2708
AN:
3470

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

May 09, 2017
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Nov 24, 2014
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Ala2132Thr in exon 53 of OTOGL: This variant is not expected to have clinical si gnificance because it has been identified in 48.3% (2123/4398) of African Americ an chromosomes from a broad population by the NHLBI Exome Sequencing Project (ht tp://evs.gs.washington.edu/EVS; dbSNP rs1551118). -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.67
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
6.0
DANN
Benign
0.20
Eigen
Benign
-0.61
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.14
T;.;T
MetaRNN
Benign
9.2e-7
T;T;T
MetaSVM
Benign
-1.0
T
PrimateAI
Benign
0.33
T
PROVEAN
Benign
2.6
.;.;N
REVEL
Benign
0.031
Sift
Benign
1.0
.;.;T
Sift4G
Benign
1.0
.;.;T
Vest4
0.038
MPC
0.022
ClinPred
0.0014
T
GERP RS
3.0
gMVP
0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1551118; hg19: chr12-80761430; COSMIC: COSV54014259; COSMIC: COSV54014259; API